chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The first thing that started was extreme chills.  I also felt light headed which resulted in fainting.  I also had a little nausea. I felt okay the morning after the vaccine.  I did have to get stiches due to my fall from fainting.  I feel like if I would have stayed in bed instead of getting out of bed I would have been fine.  I did go to Hospital for my stiches in my head.
Adenopathy: painless ipsilateral to vaccination site (left) supraclavicular/neck adenopathy noted 5 days after vaccine, then tender ipsilateral (left) axillary adenopathy noted 6 days after vaccine, along with smaller prominent right (contralateral) lymph node.
This spontaneous report as received from a pharmacist refers to a newborn female patient of unknown age. On 13-OCT-2012 12:07, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to nuts.    On 26-Oct-2021 at 11:08 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Oct-2021 at 11:08 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 26-Oct-2021 at 11:08 AM, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was stated that, the patient never diagnosed with or tested positive for COVID-19. She did not have any acute illness at the time of vaccination and up to one month before. She also did not have any chronic or long-standing health conditions. She had not taken any prescription, over-the-counter medications, dietary supplement or herbal remedies at the time of vaccination. She did not experienced the similar event in the past and there was no other potential cause to the event.  Patient did not receive any treatment for the event No concomitant medication reported.
This is a spontaneous report from a contactable physician received via a Pfizer sales representative. This physician reported similar events for 2 patients. This is second of two reports. A patient of unspecified age and gender received PREVNAR 13 (lot number and expiration date unknown) via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date (reported as 3 to 4 years ago), the patient got pneumonia after receiving pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein). The patient was tested and showed that the pneumonia strains were not covered or protected by pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein). The outcome of the event was unknown. The following information on the batch number has been requested.; Sender's Comments: Reported event pneumonia (pneumonia strains not covered by PREVNAR 13) more likely represents coincidental bacterial infection, which considered not related to PREVENAR 13.,Linked Report(s) : US-PFIZER INC-2019114309 same reporter, product, events; different patient.
Covid; Covid; This is a spontaneous report received from a contactable reporter(s) (Pharmacist). The reporter is the parent.  A 45 year-old male patient received bnt162b2 (BNT162B2, solution for injection) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Covid". The patient underwent the following laboratory tests and procedures: investigation: positive, notes: Got Covid.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the available information and a possible contributory role of suspect product BNT162B2 to the development of events drug ineffective, covid19 cannot be totally excluded.
Allergic reaction to PROQUAD vaccine (rash to left arm), we gave Benadryl. child was observed for 30 min in office. lungs were clear she left with no distress/angioedema. Advise mother to go to ER or call EMS if distressed breathing or swelling to face; follow up  in one day to assess reaction.
After I gave the vaccine in his left arm, he walked to the waiting area about 15 feet away.  He sat down, then appeared to faint, and fell on the floor.   His brother helped him back into his chair by the time I was able to run over to him.  He seemed pale.  We gave him a glucose tablet to eat to raise his blood sugar and he immediately threw it up.  We ended up calling the ambulance, and when they arrived they checked his blood sugar and pupils and he said that he had not eaten that AM.  His blood sugar was low and his pupils were reactive and they advised him to get something to eat but did not take him to the hospital.
All the following were severe and debilitating: fever >102.5F Chills Rigors Headache Nausea Malaise  Abdominal pain Lethargy Arthralgias Myalgias  Palpitations  Tachycardia  Injection site pain Flushing
Got the shot, still got Shingles/Suspected vaccination failure; Still got Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got the shot, still got Shingles/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Still got Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient got the shingles shot and still got shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Pt vaccinated for Smallpox, complaint of Headache, chest discomfort, with pustule noted on arms and torso.  Patient present to local clinic, transported to Emergency Room and ID notified.
PT got vaccine at 10:52am -- came back at 11 complaining of itching on his arm. No hives were seen and he never scratched. At 11:50, 11:20, and 11:25 am he stated that he was fine. Did not want to wait any longer and left. He signed a form saying he was ok to leave.
Patient received 4mth old shots. On 4/12 - mother reported that about 2 hours after shots patient was fussy, then an hour later patient developed 103 degrees F temp. Mother called MD on call, MD advised mom to give TYLENOL. Mother gave. Patient also vomited 3x on 4/5. And on 4/6 had 101 degrees F and vomited x2. On 4/7 -symptoms had resolved.
PATIENT CALLED AND SAID HER ARM HURTS SINCE SHE GOT THE VACCINE AND SHE IS GOING TO SEE HER DOCTOR TODAY
Rash at injection site. Approx 4" long and 1" wide. Itchy and warm.
nauseated; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other and describes the occurrence of NAUSEA (nauseated) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced NAUSEA (nauseated). At the time of the report, NAUSEA (nauseated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.   Reporter did not allow further contact
Approximately 1/3 of my daughter's arm got red, hot and hard on touch. The arm was hurting. The next day it looked like the center of the redness was darker - resembling a bruise. She was still complaining about pain. After a few days she said that arm was itching.  Still a week later her arm is dark (looks like it is bruised).
Hospitalization: 10/26/22 - 11/5/22.  Presentation to the ED: FALL W/ L HUMERUS FRACTURE & UNCONTROLLED HTN.  COVID + date: 11/4/22. Treatment: NONE, PATIENT WAS ASYMPTOMATIC AND TESTED POSITIVE ON A TRANSFER SCREEN.  Discharge to:
received 1st and only dose of Shingrix in 2018; This case was reported by a pharmacist and described the occurrence of incomplete course of vaccination in a 82-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 1st January 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional case details were reported as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of vaccine, which led to incomplete course of vaccination. The reporter consented to follow up.
Missed 2nd dose for unknown reason(s); This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Jul-2021 and was forwarded to Moderna on 20-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose for unknown reason(s)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L201) for COVID-19 vaccination.     No Medical History information was reported.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose for unknown reason(s)). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed 2nd dose for unknown reason(s)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitants were reported. No treatment was reported.
I started getting a headache on 12/22 with nasal congestion worsening over night the next day I continued having congestion and headache, I called employee health and received a covid test which was negative. I continued to have headache and congestion for two more days and the 25th I was really tired and  took a nap. By the 26th I felt completely normal
2-3 minutes after receiving H1N1 FLUMIST vaccine patient started feeling tingling in lips and tip of tongue. After about 7-10 minutes lips and tip of tongue became numb, no respiratory difficulty, throat was not numb. After 15 minutes patient reported numbness progressed to lower area around lips and nasal area, still no swelling of throat or nasal passages. Phone call to Dr. at clinic describing patient symptoms, phone order given to give BENADRYL 25mg capsule and observe for 1 hour, patient aware and capsule given po at 12:40PM. 12:50PM patient states, "The numbness is still present and has moved further down tongue but still not in throat, no problems breathing" 12:50Pm spoke with FNP about present symptoms and order given to administer BENADRYL 25mg. IM now, patient aware and regards positive; BENADRYL 25mg given in (RG) IM with inst. 1:00 patient states "It seems to be a little better, the numbness is letting up a little back of tongue. Still numb lips and around face and nose." No Sxs of respitory distress. 1:10 PM. Pt states "my tongue is getting a lot better, lips and surrounding face still numb." No Sxs of respiratory distress. LE 12:40 PM BP 120/70 AP 90b/min Respirations 14 1:30 Pm BP 120/70 AP 90 b/min Respirations 15 pt states "my tongue is still tingling just @ tip, the rest of tongue is okay now, lips and surrounding face area just tingling. I am very drowsy." 1:40 PM patient states, "just a little tingling in lips, I would like to go back to work now." Discussed not driving due to drowsiness. Discussed calling if any further problems arise. Discussed contacting PMD to report this side effect.
pt recv vax 26AUG97 & 1SEP97 pt exp 2 vesicles @ inj site that appeared to look like blisters;
This spontaneous report as received from a healthcare professional refers to an unspecified number of patients. In approximately 2015 (reported as since 13-MAR-2015), the patients were vaccinated with doses of ROTATEQ lot # K010221, K011663, K016313 and lot # reported as K015816 (expiration dates, dose, route and site of administrations were not reported) that were exposed to temperatures outside of the recommended range. No adverse effects had been observed or reported. This is one of several reports from the same reporter. Additional information has been requested.
Extreme vertigo that has persisted since 1/4. Unsure if this is a vaccine side effect or unrelated.
This spontaneous report has been received from a nurse practitioner regarding a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated (Oka/Merck) VARIVAX dose 1, (dose, lot # and expiry date unknown). On 03-MAY-2012, the patient received improperly stored (Oka/Merck) VARIVAX dose 2, from lot # 1273AA (dose, vaccination site, route, expiry date unknown). No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of several reports received from the same reporter. Additional information has been requested.
burning of the eyes; it taste like black pepper; This spontaneous case was reported by a consumer and describes the occurrence of EYE IRRITATION and TASTE DISORDER in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced EYE IRRITATION and TASTE DISORDER. On 02-Apr-2021, EYE IRRITATION had resolved. On 04-Apr-2021, TASTE DISORDER had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC-MOD-2021-073889. Sender's Comments:  US-MODERNATX, INC-MOD-2021-073889: Dose 2.
Muscle aches, headache, fever, chills. Lasted about 12 hours.
The morning after the booster shot (11/4/2021) I went to the ER around 11:30 AM. I had been experiencing heart palpitations (heart rate over 200 bpm when I entered the ER). I was given magnesium IV, and I do not recall any other medication being administered. They had me hooked up to monitors. The heart palpitations and I was allowed to leave the ER, with a referral to a cardiologist, and a 1 week holter monitor. After seeing the cardiologist about a week and a half later, had an EKG and angiogram, both came back normal. It's important to note I have had minor heart palpitations, very infrequently since my 20's. However, these were much more severe than anything I had experienced before.
Tenderness in lymph node located in the armpit of the same arm as the injection site.
Lip swelling - sl. facial swelling & flushing -  no respiratory difficulty (known allergy to egg, milk, Inhalants).
Stomach cramps; This case was reported by a pharmacist and described the occurrence of stomach cramps in a 56-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 4th December 2020, the patient received the 2nd dose of Shingrix. In December 2020, 1 week after receiving Shingrix, the patient experienced stomach cramps. On an unknown date, the outcome of the stomach cramps was unknown.   It was unknown if the reporter considered the stomach cramps to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient who one week after receiving the dose of Shingrix experienced stomach cramps. The reporter consented to follow up.  No other information provided.
Swelling and erythema in left arm from deltoid muscle to elbow. Tenderness in left shoulder and neck area and tingling in left hand. No fever. Symptoms continued until the evening of 8/5/00. Treatment: Motrin 800mg
register pregnancy; vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of PREGNANCY (register pregnancy) and EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 05-Feb-2021 and the estimated date of delivery was 12-Nov-2021. On 02-Aug-2021, the patient experienced EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy). On an unknown date, the patient experienced PREGNANCY (register pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-fifth week of the pregnancy.  On 02-Aug-2021, EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy) had resolved. At the time of the report, PREGNANCY (register pregnancy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications included prenatal vitamins and nausea medication.  No treatment medications were reported.
The excursion expiration date of 7 days thawed was followed because of the Pfizer meal approving the 7 days. Pharmacy policy was to follow  the expiration of 5 days.
I saw patient's wife in the store and ask how he was doing. She said he is doing fine. She mentioned that he had a bit of redness at the site and swelling but he is doing good now.
was sick for 3 months; Initial information was received on 12-Nov-2020 regarding an unsolicited valid non-serious social media case from a consumer via Social media.  This case involves a patient (unknown demography) who was sick for 3 months (illness), while the patient received vaccine INFLUENZA VACCINE.  Medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious was sick for 3 months (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information available on the batch number for this case.
Pain radiated into my scapula; started having pain/ unable to use the left arm/ arm hurt at rest and severe with movement; unable to sleep; The pain is with rotation of the left arm and lifting/ arm hurt at rest and severe with movement; Second dose was given in incorrect location, top/posterior area of left shoulder, not within the deltoid muscle.; This is a spontaneous report from a contactable other hcp.   A 34-year-old female patient received second dose of bnt162b2 (BNT162B2, solution for injection, Lot Number: ER8733, expiry date was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 01Apr2021 12:00 as (Age at vaccination was 34-year-old), as dose 2, single for COVID-19 immunization. Patient was not pregnant at the time of vaccination. Medical history included hypertension from an unknown date and unknown if ongoing. No allergies to medications, food, or other products were reported. There were no concomitant medications. The patient previously received first dose bnt162b2 (BNT162B2, solution for injection, Lot Number: EN6206, expiry date was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on Mar2021 04:00 PM as dose 1, single for COVID-19 immunization.On 01Apr2021 12:00, the patient experienced second dose was given in incorrect location, top/posterior area of left shoulder, not within the deltoid muscle, On 01Apr2021 15:00 pain radiated into my scapula, started having pain/ unable to use the left arm/ arm hurt at rest and severe with movement, unable to sleep, the pain was with rotation of the left arm and lifting/ arm hurt at rest and severe with movement. Patient received no treatment for the event. The patient had not received any other vaccine within 4 weeks. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The events were non-serous. The clinical outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
ZOSTAVAX administered 2-25-08. Patient presented with dermatomal rash on 11-30-10. Culture proved this was due to Varicella Zoster Virus.